Vaccination with plasmid DNA activates dendritic cells via toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice

被引:157
|
作者
Spies, B [1 ]
Hochrein, H [1 ]
Vabulas, M [1 ]
Huster, K [1 ]
Busch, DH [1 ]
Schmitz, F [1 ]
Heit, A [1 ]
Wagner, H [1 ]
机构
[1] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 171卷 / 11期
关键词
D O I
10.4049/jimmunol.171.11.5908
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We analyzed whether the immunobiology of vaccinating plasmid DNA containing a transcription unit for OVA is influenced by immunostimulatory CpG motifs in the plasmid backbone. Indeed, plasmid DNA differentially activated in vitro myeloid and plasmacytoid dendritic cells (DCs) provided they expressed the CpG-DNA receptor, Toll-like receptor 9 (TLR9). Dependent on the DC subset, activation resulted in type 1 IFN production, while both DC subsets produced IL-6 and up-regulated expression of costimulatory molecules CD40 and CD86. In vivo, however, even upon repeated vaccination with plasmid DNA, priming of OVA-specific CTL and clonal expansion of SIINFEKL-specific CD8 T cells were equal in TLR9-positive and TLR9- or MyD88-negative mice. Overall, these results negate a dominant role of CpG-DNA/TLR9 interactions in long-term vaccination protocols.
引用
收藏
页码:5908 / 5912
页数:5
相关论文
共 50 条
  • [32] TOLL-LIKE RECEPTOR 9 (TLR9) PLAYS AN ESSENTIAL ROLE IN INJURY-INDUCED TREG ACTIVATION
    Guo, Fei
    Zhang, Fan
    Cahill, Laura A.
    Keegan, Joshua W.
    Nguyen, Jannifer P.
    Griffith, Alec M.
    Ng, Julie
    Lederer, James A.
    SHOCK, 2019, 51 (06): : 101 - 101
  • [33] Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9)
    Peixoto-Rangel, Alba L.
    Miller, E. Nancy
    Castellucci, Lea
    Jamieson, Sarra E.
    Peixe, Ricardo Guerra
    Elias, Liliani de Souza
    Correa-Oliveira, Rodrigo
    Bahia-Oliveira, Lilian M. G.
    Blackwell, Jenefer M.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2009, 104 (08): : 1187 - 1190
  • [34] Association toll-like receptor TLR 2, TLR 4 and TLR9 gene polymorphisms with COVID-19 severity
    Al-Jawadi, Ali
    Pokudina, Inna
    Shkurat, Tatiana
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 172 - 172
  • [35] Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis
    Holle, Julia U.
    Windmoeller, Mirca
    Lange, Christina
    Gross, Wolfgang L.
    Herlyn, Karen
    Csernok, Elena
    RHEUMATOLOGY, 2013, 52 (07) : 1183 - 1189
  • [36] Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis
    Hamann, L
    Glaeser, C
    Hamprecht, A
    Gross, M
    Gomma, A
    Schumann, RR
    CLINICA CHIMICA ACTA, 2006, 364 (1-2) : 303 - 307
  • [37] Toll-like receptor (TLR)-9 genetics and function in sarcoidosis
    Veltkamp, M.
    van Moorsel, C. H. M.
    Rijkers, G. T.
    Ruven, H. J. T.
    van den Bosch, J. M. M.
    Grutters, J. C.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 162 (01): : 68 - 74
  • [38] Role of toll like receptor 9 (TLR9) in astroglial function: focus on glutamate transporters
    Pallottie, A.
    Ratnayake, A.
    Ni, L.
    Heary, R.
    Elkabes, S.
    GLIA, 2017, 65 : E436 - E437
  • [39] Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9
    Tomoki Ito
    Yui-Hsi Wang
    Yong-Jun Liu
    Springer Seminars in Immunopathology, 2005, 26 : 221 - 229
  • [40] Expressional correlation of Toll-like Receptor 9 (TLR9) with angiogenic factors and anti-apoptotic markers in cervical cancer cells
    Alharbi, Ahmed
    Alshammari, Waleed Mansi
    Alreshidi, Turki A. K.
    AIMS MEDICAL SCIENCE, 2021, 8 (01): : 11 - 22